The mental health startup Cerebral benefited from pandemic-era changes to federal telehealth laws. But its easy-to-get prescriptions for tightly regulated stimulants — heavily promoted on social media — have sparked a Department of Justice investigation.This episode was produced by Tori Dominguez, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Paul Mounsey, and hosted by Sean Rameswaram.Transcript at <a href="http://vox.com/todayexplained">vox.com/todayexplained</a>  Support Today, Explained by making a financial contribution to Vox! <a href="http://bit.ly/givepodcasts">bit.ly/givepodcasts</a> Learn more about your ad choices. Visit <a href="https://podcastchoices.com/adchoices">podcastchoices.com/adchoices</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Adderall via Instagram

Today, Explained